Catalyst Wire Dossier Catalyst Wire Dossier

Kremezin

AST-120
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Kremezin, covering 2014-03-19 to 2025-09-19. Get the full timeline:

Most recent: Clinical Trial Update: AST-120 (Kremezin®) for the Renal Protection and Attenuation of Decline in Acute Kidney Disease [Phase 4]

See pricing